Company Monitoring Page for Merck

latest headlines for company on cafepharma

Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
Tags:
R&D, Roche, JNJ, Merck, Pfizer, Novartis, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Sanofi, AbbVie
In new PD-1 showdown, GSK's Jemperli loses initial edge on Merck's Keytruda
Fierce Pharma
Mon, 03/27/23 - 10:09 pm
Tags:
GSK, Merck, Keytruda, Jemperli, cancer
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wed, 03/22/23 - 10:03 am
Tags:
AACR, Moderna Therapeutics, Allogene, AstraZeneca, Merck, Roche, Novartis, Eli Lilly, Innovent, Springworks, Biogene, Relay Therapeutics, Vivace Therapeutics
Mer­ck, Vi­a­tris agree to set­tle patent feud sur­round­ing di­a­betes drugs
Endpoints
Mon, 03/20/23 - 04:30 pm
Tags:
Merck, Viatris, patents, diabetes, Januvia, Janumet
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
CP WIre
Sat, 03/18/23 - 03:37 pm
Tags:
Medtronic, Medtech, inflation, drug pricing, Pfizer, Novartis, Merck, Bristol Myers Squibb, Keytruda, Opdivo, Yervoy, lung cancer, Xiidra, JNJ, executive compensation
Sat, 03/18/23 - 03:34 pm
Tags:
Medtronic, Medtech, inflation, drug pricing, Pfizer, Novartis, Merck, Bristol Myers Squibb, Keytruda, Opdivo, Yervoy, lung cancer, Xiidra, JNJ, executive compensation
Merck's TIGIT fails in phase 2 Keytruda combo, notching another loss for the class
Fierce Biotech
Thu, 03/16/23 - 07:02 pm
Tags:
Merck, Keytruda, clinical trials, vibostolimab, non-small cell lung cancer, metastatic non-small cell lung cancer
Keytruda Unlocked: How Should Merck Proceed with Trials?
BioSpace
Tue, 03/14/23 - 11:19 am
Tags:
Keytruda, Merck, cancer, clinical trials
Merck asks EMA to reevaluate rejected Covid-19 antiviral
Endpoints
Mon, 03/13/23 - 04:40 pm
Tags:
Merck, Europe, EMA, COVID-19, Lagevrio, molnupiravir, antivirals
Merck reports positive data from malignant pleural mesothelioma trial
Clinical Trials Arena
Mon, 03/13/23 - 10:01 am
Tags:
Merck, Canadian Cancer Trials Group, clinical trials, Keytruda, mesothelioma
In PD-1 rivalry, Merck's Keytruda catches up with Opdivo in rare lung cancer type
Fierce Pharma
Fri, 03/10/23 - 11:20 am
Tags:
Merck, Keytruda, Opdivo, Bristol Myers Squibb, pleural mseothelioma, mesothelioma, clinical trials
Merck pays $50 million for early-stage Epstein-Barr vaccine
BioPharma Dive
Wed, 03/8/23 - 09:49 pm
Tags:
Merck, OPKO Health, vaccines, Epstein-Barr virus
Merck’s oral cholesterol-lowering drug shows similar efficacy to injectable predecessors as it moves to PhIII: #ACC23
Endpoints
Mon, 03/6/23 - 11:15 pm
Tags:
Merck, PAH, clinical trials, MK-0616
FDA asks advisers to review Lynparza amid growing scrutiny of PARP drugs
BioPharma Dive
Sun, 03/5/23 - 03:08 pm
Tags:
Merck, AstraZeneca, Lynparza, FDA, PARP inhibitors
Spotlight – What is next in Nash
EP Vantage
Fri, 03/3/23 - 10:02 am
Tags:
NASH, clinical trials, 89Bio, Arrowhead Pharmaceuticals, Can-Fite BioPharma, Ewopharma, Hepagene Therapeutics, JNJ, Ligand Pharmaceuticals, Madrigal Pharmaceuticals, Merck, NGM Biopharmaceuticals, NorthSea Therapeutics, Novartis, Sagimet Biosciences, Terns Pharmaceuticals, Viking Therapeutics
AstraZeneca, Merck's Lynparza to face FDA panel in prostate cancer bid as PARP scrutiny escalates
Fierce Pharma
Thu, 03/2/23 - 11:02 pm
Tags:
AstraZeneca, Merck, Lynparza, FDA, prostate cancer
Merck reports two Phase 3 study misses for Keytruda
BioPharma Dive
Tue, 02/28/23 - 10:43 pm
Tags:
Merck, clinical trials, Keytruda, prostate cancer, lung cancer
Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report
Fierce Pharma
Tue, 02/28/23 - 10:39 pm
Tags:
Medicare, drug pricing, Merck, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, JNJ
Keytruda killer: Chipscreen bags Chinese rights to Biocytogen's bispecific antibody
Fierce Biotech
Tue, 02/28/23 - 09:56 am
Tags:
cancer, Biocytogen, Chipscreen NewWay Biosciences, Merck, Keytruda, YH008
Warren urges US patent office to scrutinize Merck's efforts with Keytruda
Fierce Pharma
Thu, 02/23/23 - 04:25 pm
Tags:
Merck, Keytruda, Senate, Elizabeth Warren, patents

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.